Get a glimpse into our company and investor data—powered by the PitchBook Platform
Focal Point Pharmaceuticals
Early Stage VCLATEST DEAL TYPE
$80KLATEST DEAL AMOUNT
Developer of products designed to treat ocular diseases. The company's products are developed with pre-clinical research and lead selection, enabling clients to treat rare diseases, including ocular trauma and other eye diseases.